The European Society for Medical Oncology (ESMO) Congress featured findings on overall survival, disparities, and artificial ...

A clinical trial manager emphasizes the importance of a phased approach to educating patients about complex protocols and ...

(NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address Oncology and Inflammatory diseases, today announced that its work ...

Can-Fite BioPharma announced that its liver-protective drug, Namodenoson, will be presented at the 2025 ASCO Gastrointestinal Cancers Symposium. Namodenoson is currently in a Phase 3 trial for ...

Dayton, which knocked off UConn in nonconference play, looks to be the favorite as Atlantic 10 conference play begins on ...

Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next ...

Patrik Laine scored the League's 100th hat trick of the 2024 calendar year (regular season & playoffs combined) and his first ...

We work right across the cancer research pathway with strengths ranging from cell biology to healthcare research. We aim to nurture the thought leaders of today and tomorrow through the provision of ...

For a while, one of the Philadelphia Flyers‘ biggest weaknesses was their shorthanded unit. Between 2014-15 and 2022-23—a nine-season span—they were above the league average in penalty kill ...

When someone is diagnosed with cancer, the focus is usually on finding the most successful treatment options. But there’s more to dealing with cancer than medical therapies and procedures. Cancer may ...

Medscape Oncology, April 13, 2016 National Comprehensive Cancer Network (NCCN) 21st Annual Conference Read clinically focused news coverage of key developments from NCCN 2016. Medscape Oncology ...

To tackle this growing problem, the ESC is launching a new conference on cardio-oncology to specifically target this increasingly important area that overlaps cancer treatment and its associated ...